B-cell Lymphoid Malignancies
4 clinical trials · Condition
◉ Watch B-cell Lymphoid Malignancies
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies (NCT05263739) | Shanghai Escugen Biotechnology Co., Ltd | 2025-12-01 |
| A Phase 1 Study of ESG206 in Adult Subjects With B-cell Lymphoid Malignancies (NCT05822843) | Shanghai Escugen Biotechnology Co., Ltd | 2023-08-02 |
| Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies (NCT04684979) | Baptist Health South Florida | 2022-03-28 |
| BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies (NCT02569476) | BeiGene | 2016-01-13 |
Track B-cell Lymphoid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.